miR-455-5p may exert tumor promoting roles by inhibiting the expression of CDKN1B and influencing cell cycle and miR-1255a may be oncogenic by down-regulating SMAD4 and affecting TGF-β signaling pathway, which resulted in poor prognosis. Here, SMAD4 is linked to neoplasm.